Asset
NALOXONE HYDROCHLORIDE
Emergent BioSolutions Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (0)
No records yet.
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 208411 | NDA | EMERGENT OPERATIONS IRELAND LTD |
Marketed products (2)
- NARCAN
- NARCAN